Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00399347
Status:
COMPLETED
Last Update Posted:
2022-08-25
First Post:
2006-11-12
Brief Title:
Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel an Update
Sponsor:
HaEmek Medical Center Israel
Organization:
HaEmek Medical Center Israel
Study Overview
Official Title:
Prevalence of Diabetes Mellitus in Ethiopian Community in Israel an Update
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The prevalence and incidence of diabetes has been reported to vary among populationsImmigrants groups as that have undergone significant life-style changes tend to develop diabetes within a short time The aim of the study is to assess the prevalence of diabetes mellitus in Ethiopian population 15-20 years after immigration in Israel
Detailed Description:
The study will be conducted in three primary care clinics of the Jezreel Valley Omer Givat Hamore and Afula Illit The computerized medical charts of 500 Ethiopian adults will be reviewed The following information will be obtained age date of arrival in Israel known history of diabetes hyperlipidemia hypertension or other disease drug therapy body weight blood pressure Following laboratory data will be retrieved blood glucose HbA1c lipid levels creatinine and uric acid The criteria used for the definition of diabetes will be based on the criteria proposed by the American Diabetes Association
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None